Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 300.64 Million | USD 1002.62 Million | 12.8% | 2024 |
FrequentlyAsked Questions
The global microbial therapeutic products market is expected to grow due to increasing antibiotic resistance, rising prevalence of chronic diseases, growing demand for personalized medicine, and expanding applications in oncology and immunology.
According to a study, the global microbial therapeutic products market size was worth around USD 300.64 Million in 2024 and is expected to reach USD 1002.62 Million by 2034.
The global microbial therapeutic products market is expected to grow at a CAGR of 12.8% during the forecast period.
North America is expected to dominate the microbial therapeutic products market over the forecast period.
Leading players in the global microbial therapeutic products market include Mylan N.V., F. Hoffmann La-Roche Ltd., Novartis AG, Amgen Inc., Merck & Co. Inc., Biocon, Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Bristol-Myers Squibb Company, Abbot Laboratories, among others.
The report explores crucial aspects of the microbial therapeutic products market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed